Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection

Mostrar otras versiones (1)

INTRODUCTION: Treating systemic inflammation caused by SARS-COV 2 (COVID-19) has become a challenge for the clinician. Corticosteroids have been the turning point in the treatment of this disease. Preliminary data from Recovery clinical trial raises hope by showing that treatment with dexamethasone...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarriá-Landete, Antonio J., Crespo-Matas, José A., Domínguez-Quesada, Inmaculada, Castellanos-Monedero, Jesús J., Marte-Acosta, Dinés, Arias-Arias, Ángel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212640/
https://www.ncbi.nlm.nih.gov/pubmed/35718548
http://dx.doi.org/10.1016/j.medcli.2022.02.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212640/
https://www.ncbi.nlm.nih.gov/pubmed/35718548
http://dx.doi.org/10.1016/j.medcli.2022.02.025

Ejemplares similares